07.01.2015 Views

Read the full Annual Report in PDF format - CSIR

Read the full Annual Report in PDF format - CSIR

Read the full Annual Report in PDF format - CSIR

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Interests of <strong>the</strong> <strong>CSIR</strong><br />

Net <strong>in</strong>debtness less accumulated impairment losses Net <strong>in</strong>vestment General nature of bus<strong>in</strong>ess<br />

to subsidiaries by subsidiaries<br />

2011 2010 2011 2010 2011 2010<br />

R’000 R’000 R’000 R’000 R’000 R’000<br />

- - 12 000 13 262 16 650 17 912 The acquisition and transfer of technology to<br />

<strong>in</strong>dustry by licens<strong>in</strong>g new <strong>in</strong>ventions, provid<strong>in</strong>g<br />

fi nance to develop technology and venture<br />

capital for <strong>the</strong> exploitation <strong>the</strong>reof.<br />

- - 4 361 4 464 4 361 4 464 The company sources technologies and<br />

entrepreneurs from <strong>the</strong> <strong>CSIR</strong>, o<strong>the</strong>r S&T <strong>in</strong>stitutions,<br />

universities or any developer of technology and<br />

develops <strong>the</strong>se <strong>in</strong>to viable bus<strong>in</strong>esses with <strong>the</strong><br />

aim of sp<strong>in</strong>n<strong>in</strong>g <strong>the</strong>m off for capital ga<strong>in</strong> and/or<br />

public good.<br />

- - 4 727 4 800 5 185 5 153 The pr<strong>in</strong>cipal activity of <strong>the</strong> company is that of<br />

consult<strong>in</strong>g on technology audit<strong>in</strong>g, technology<br />

evaluation and technology transfer on behalf of<br />

clients <strong>in</strong> <strong>the</strong> public and private sectors.<br />

- - 21 088 22 526 26 196 27 529<br />

The company manufactures and distributes high<br />

technology cameras for use <strong>in</strong> detect<strong>in</strong>g faults on<br />

overhead electricity distribution l<strong>in</strong>es.<br />

The pr<strong>in</strong>cipal activities of <strong>the</strong> company are to<br />

develop, commercialise and market naturally<br />

derived products for <strong>the</strong> biotechnology and<br />

pharmaceutical markets.<br />

167 ANNUAL FINANCIAL STATEMENTS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!